Tamoxifen and Risk of Contralateral Breast Cancer for <i>BRCA1</i> and <i>BRCA2</i> Mutation Carriers
Kelly‐Anne Phillips(The University of Melbourne), John L. Hopper(Ste. Anne's Hospital), Rob A.�E.�M. Tollenaar(Leiden University Medical Center), Kate Birch(Ste. Anne's Hospital), Roger L. Milne(The University of Melbourne), Lenka Foretová(Masaryk Memorial Cancer Institute), Esther M. John, Irene L. Andrulis(University of Toronto), Anna Jakubowska(Pomeranian Medical University), Jacques Simard(Université Laval), Mary Beth Terry(Columbia University Irving Medical Center), Maartje J. Hooning(Erasmus MC Cancer Institute), Saundra S. Buys(University of Utah), Anne‐Marie Gerdes(Copenhagen University Hospital), Prue C. Weideman(Ste. Anne's Hospital), Nadine Andrieu(Inserm), Melissa C. Southey(The University of Melbourne), Debra Frost(Ste. Anne's Hospital), Caroline Seynaeve(Radboud University Nijmegen), Pascal Pujol(Inserm), Sue Anne McLachlan(The University of Melbourne), Antonis C Antoniou(University of Cambridge), Edith Olah(Ste. Anne's Hospital), Mary B. Daly(Fox Chase Cancer Center), Dominique Stoppa-Lyonnet(Ste. Anne's Hospital), David E. Goldgar(Ste. Anne's Hospital), Valérie Bonadona(Centre Léon Bérard), Douglas F. Easton(Ste. Anne's Hospital), Christian F. Singer(Ste. Anne's Hospital), Trinidad Caldés(Instituto de Investigación Sanitaria del Hospital Clínico San Carlos), Susan Peock(Cancer Research UK), Catherine Noguès(Inserm), Håkan Olsson(Nokia (Finland)), Matti A. Rookus(Ste. Anne's Hospital), Michael Friedländer(Prince of Wales Hospital)
Cited by 171
Related Papers
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k
Mortality Results from a Randomized Prostate-Cancer Screening Trial
|New England Journal of Medicine|2009|2.9k
Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer
|New England Journal of Medicine|2018|2.9k